Symbiotec Pharmalab IPO sees subscription at 0.70x by mid-afternoon
Symbiotec Pharmalab Ltd’s initial public offering (IPO) received bids for 9,168,240 shares, achieving a subscription rate of 0.70 times by 3:30 PM on its first day. The ₹1,757 crore issue, priced at ₹938–988 per share, is open until August 27. The company’s strong market position in corticosteroid APIs may influence investor interest moving forward.